Muscleblind-like1 undergoes Ectopic relocation in the nuclei of skeletal muscles in myotonic dystrophy and sarcopenia

European Journal of Histochemistry

Volumn 57, Issue 2, 2013, Pages 86-92

  Malatesta, M ^a   Giagnacovo, M ^b   Costanzo, M ^a   Cisterna, B ^a   Cardani, R ^c   Meola, G ^c,d  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c IRCCS POLICLINICO SAN DONATO   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Cell nucleus; MBNL1; Myotonic dystrophy; Sarcopenia; Skeletal muscle

Indexed keywords

MUS;

DNA BINDING PROTEIN; MBNL1 PROTEIN, HUMAN; MBNL1 PROTEIN, MOUSE; RNA BINDING PROTEIN;

ADOLESCENT; ADULT; ANIMAL; CELL NUCLEUS; HUMAN; METABOLISM; MIDDLE AGED; MOUSE; MYOTONIC DYSTROPHY; PATHOLOGY; PROTEIN TRANSPORT; SARCOPENIA; SKELETAL MUSCLE; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANIMALS; BLOTTING, WESTERN; CELL NUCLEUS; DNA-BINDING PROTEINS; HUMANS; MICE; MIDDLE AGED; MUSCLE, SKELETAL; MYOTONIC DYSTROPHY; PROTEIN TRANSPORT; RNA-BINDING PROTEINS; SARCOPENIA;

EID: 84892635431     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/ejh.2013.e15     Document Type: Article

References (72)

1. Ho TH, Charlet BN, Poulos MG, Singh G, Swanson MS, Cooper TA. Muscleblind proteins regulate alternative splicing. EMBO J 2004;23:3103-3112.
2. Pascual M, Vicente M, Monferrer L, Artero R. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing. Differentiation 2006;74:65-80.
3. Llorian M, Smith CWJ. Decoding muscle alternative splicing. Curr Opin Genet Develop 2011;21:380-387.
4. Houseley JM, Wang Z, Brock GJ, Soloway J, Artero R, Perez-Alonso M, et al. Myotonic dystrophy associated expanded CUG repeat muscleblind positive ribonuclear foci are not toxic to Drosophila. Hum Mol Genet 2005;14:873-883.
5. Onishi H, Kino Y, Morita T, Futai E, Sasagawa N, Ishiura S. MBNL1 associates with YB-1 in cytoplasmic stress granules. J Neurosci Res 2008;86:1994-2002.
6. Black DL. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 2003;72:291-336.
7. Fernandez-Costa JM, Llamusi MB, Garcia-Lopez A, Artero R. Alternative splicing regulation by Muscleblind proteins: from development to disease. Biol Rev 2011;86: 947-958.
8. Vihola A, Bassez G, Meola G, Zhang S, Haapasalo H, Paetau A, et al. Histopa -thological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 2003;60:1854-1857.
9. Bachinski LL, Udd B, Meola G, Sansone V, Bassez G, Eymard B, et al. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myoton-ic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Am J Hum Gen 2003;73:835-848.
10. rd. Myotonic dystrophy type 2 and related myotonic disorders. J Neurol 2004;251:1173-1182.
11. Savkur RS, Philips AV, Cooper TA. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 2001;29: 40-47.
12. Savkur RS, Philips AV, Cooper TA, Dalton JC, Moseley ML, Ranum LP, et al. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 2004;74:1309-1313.
13. Day JW, Ricker K, Jacobsen J F, Rasmussen LJ, Dick KA, Kress W, et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 2003;60:657-664.
14. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992; 69:385-387.
15. Fu YH, Pizzuti A, Fenwick RG Jr, King J, Rajnarayan S, Dunne PW, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256-1258.
16. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 1992;255:1253-1255.
17. Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH. Foci of trinu-cleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 1995;128:995-1002.
18. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001;293:864-867.
19. Ranum LP, Rasmussen PF, Benzow KA, Koob MD, Day JW. Genetic mapping of a second myotonic dystrophy locus. Nat Genet 1998;19:196-198.
20. Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, Harper PS, et al. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 2002;11:805-814.
21. Mankodi A, Urbinati CR, Yuan QP, Moxley RT, Sansone V, Krym M, et al. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet 2001;10:2165-21670.
22. Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, Thornton CA, et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 2000;19:4439-4448.
23. Kini Y, Mori D, Oma Y, Takeshita Y, Sasagawa N, Ishiura S. Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats. Hum Mol Genet 2004;13: 495-507.
24. Lin X, Miller JW, Mankodi A, Kanadia RN, Yuan Y, Moxley RT, et al. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet 2006;15:2087-2097.
25. Kalsotra A, Xiao X, Ward AJ, Castle JC, Johnson JM, Burge CB, et al. A postnatal switch of CELF and MBNL proteins repro-grams alternative splicing in the developing heart. Proc Natl Acad Sci USA 2008;105:20333-20338.
26. Terenzi F, Ladd AN. Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity. RNA Biol 2010; 7:43-55.
27. Ranum LP, Cooper TA. RNA-mediated neu-romuscular disorders. Annu Rev Neurosci 2006;29:259-277.
28. Warf MB, Diegel JV, von Hippel PH, Berglund JA. The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing. PNAS 2009; 106:9203-9208.
29. Koebis M, Ohsawa N, Kino Y, Sasagawa N, Nishino I, Ishiura S. Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1. Genes Cells 2011;16:961-972.
30. Rinaldi F, Terracciano C, Pisani V, Massa R, Loro E, Vergani L, et al. Aberrant splicing and expression of the non muscle myosin heavy-chain gene MYH14 in DM1 muscle tissues. Neurobiol Dis 2012;45: 264-271.
31. Fugier C, Klein AF, Hammer C, Vassilopoulos S, Ivarsson Y, Toussaint A, et al. Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nature Med 2011;17:720-726.
32. Charlet BN, Savkur RS, Singh G, Philips AV, Grice EA, Cooper TA. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 2002;10:45-53.
33. Tang ZZ, Yarotskyy V, Wei L, Sobczak K, Nakamori M, Eichinger K, et al. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel. Hum Mol Genet 2012;21:1312-1324.
34. Paul S, Dansithong W, Kim D, Rossi J, Webster NJG, Comai L, et al. Interaction of musleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. EMBO J 2006;25:4271-4283.
35. Perdoni F, Malatesta M, Cardani R, Giagnacovo M, Mancinelli E, Meola G, et al. RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocy-tochemical study. Eur J Histochem 2009; 53:151-158.
36. Fakan S. Ultrastructural cytochemical analyses of nuclear functional architecture. Eur J Histochem 2004;48:5-14.
37. Malatesta M, Giagnacovo M, Cardani R, Meola G, Pellicciari C. RNA processing is altered in skeletal muscle nuclei of patients affected by myotonic dystrophy. Histochem Cell Biol 2011;135:419-425.
38. Biggiogera M, Cisterna B, Spedito A, Vecchio L, Malatesta M. Perichromatin fibrils as early markers of transcriptional alterations. Differentiation 2008;76:57-65.
39. Malatesta M, Perdoni F, Muller S, Zancanaro C, Pellicciari C. Nuclei of aged myofibres undergo structural and func-tional changes suggesting impairment in RNA processing. Eur J Histochem 2009; 53:97-106.
40. Malatesta M, Perdoni F, Muller S, Pellicciari C, Zancanaro C. Pre-mRNA processing is partially impaired in satellite cell nuclei from aged muscles. J Biomed Biotechnol 2010;2010:410405.
41. Malatesta M, Fattoretti P, Giagnacovo M, Pellicciari C, Zancanaro C. Physical training modulates structural and functional features of cell nuclei in type II myofibers of old mice. Rejuvenation Res 2011;14:543-552.
42. Cruz-Jentoft AJ, Baeyens J P, Bauer JM, Boirie Y, Cederholm T, Landi F, et al.; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412-423.
43. Edstrom E, Altun M, Bergman E, Johnson H, Kullberg S, Ramírez-León V, et al. Factors contributing to neuromuscular impairment and sarcopenia during aging. Physiol Behav 2007;92:129-135.
44. Malatesta M, Meola G. Structural and functional alterations of the cell nucleus in skeletal muscle wasting: the evidence in situ. Eur J Histochem 2010;54:e44.
45. Lattanzi G, Marmiroli S, Facchini A, Maraldi NM. Nuclear damages and oxida-tive stress: new perspectives for laminopathies. Eur J Histochem 2012;56: e45.
46. Malatesta M. Skeletal muscle features in myotonic dystrophy and sarcopenia: do similar nuclear mechanisms lead to skeletal muscle wasting? Eur J Histochem 2012; 56:e36.
47. Udd B, Meola G, Krahe R, Wansink DG, Bassez G, Kress W, et al. Myotonic dystrophy type 2 (DM2) and related disorders report of the 180th INMC workshop including guidelines on diagnostics and management 3-5 December 2010, Naarden, The Netherlands. Neuromuscl Disord 2011;21:443-450.
48. Lexell J. Human aging, muscle mass, and fibre type composition. J Gerontol A Biol Sci Med Sci 1995;50:11-16.
49. Bernhard W. A new staining procedure for electron microscopical cytology. J Ultrastruct Res 1969;27:250-265.
50. Malatesta M, Baldelli B, Battistelli S, Fattoretti P, Bertoni-Freddari C. Aging affects the distribution of the circadian CLOCK protein in rat hepatocytes. Microsc Res Tech 2005;68:45-50.
51. Malatesta M, Fattoretti P, Baldelli B, Battistelli S, Balietti M, Bertoni-Freddari C. Effects of ageing on the fine distribu-tion of the circadian CLOCK protein in reticular formation neurons. Histochem Cell Biol 2007;127:641-647.
52. Cardani R, Mancinelli E, Rotondo G, Sansone V, Meola G. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2. Eur J Histochem 2006;50:177-182.
53. Fakan S, Leser G, Martin TE. Ultrastructural distribution of nuclear ribonu-cleoproteins as visualized by immunocyto-chemistry on thin sections. J Cell Biol 1984;98:358-363.
54. Cmarko D, Verschure PJ, Martin TE, Dahmus ME, Krause S, Fu XD, et al. Ultrastructural analysis of transcription and splicing in the cell nucleus after bromo-UTP microinjection. Mol Biol Cell 1999;10:211-223.
55. Spector DL, Fu X-D, Maniatis T. Associations between distinct pre-mRNA splicing components and the cell nucleus. EMBO J 1991;10:3467-3481.
56. Schul W, Groenhout B, Koberna K, Takagaki Y, Jenny A, Manders EM, et al. The RNA 3' cleavage factors CstF 64 kDa and CPSF 100 kDa are concentrated in nuclear domains closely associated with coiled bodies and newly synthesized RNA. EMBO J 1996;15:2883-2892.
57. Cardinale S, Cisterna B, Sonetti P, Aringhieri C, Biggiogera M, Barabino SML. Subnuclear localization and dynamics of the pre-mRNA 3' end processing factor CFIm68. Mol Biol Cell 2007;18:1282-1292.
58. Puvion E, Puvion-Dutilleul F. Ultrastructure of the nucleus in relation to transcription and splicing: roles of perichromatinfibrils and interchromatin granules. Exp Cell Res 1996;229:217-225.
59. Bogolyubov D, Stepanova I, Parfenov V. Universal nuclear domains of somatic and germ cells: some lessons from oocyte interchromatin granule cluster and Cajal body structure and molecular composition. Bioessays 2009;31:400-409.
60. Hall LL, Smith K P, Byron M, Lawrence JB. Molecular anatomy of a speckle. Anat Rec A Discov Mol Cell Evol Biol 2006;288:664-675.
61. Smith K P, Byron M, Johnson C, Xing Y, Lawrence JB. Defining early steps in mRNA transport: mutant mRNA in myoton-ic dystrophy type I is blocked at entry into SC-35 domains. J Cell Biol 2007;178:951-964.
62. Biggiogera M, Bottone MG, Scovassi AI, Soldani C, Vecchio L, Pellicciari C. Rearrangement of nuclear ribonucleopro-tein (RNP)-containing structures during apoptosis and transcriptional arrest. Biol Cell 2004;96:603-615.
63. Malatesta M, Biggiogera M, Cisterna B, Balietti M, Bertoni-Freddari C, Fattoretti P. Perichromatin fibrils accumulation in hepatocyte nuclei reveals alterations of pre-mRNA processing during ageing. DNA Cell Biol 2010;29:49-57.
64. Malatesta M, Biggiogera M, Baldelli B, Barabino SML, Martin TE, Zancanaro C. Hibernation as a far-reaching program for the modulation of RNA transcription. Microsc Res Tech 2008;71:564-572.
65. Giagnacovo M, Malatesta M, Cardani R, Meola G, Pellicciari C. Nuclear ribonucleo-protein-containing foci increase in size innon-dividing cells from patients with myotonic dystrophy type 2. Histochem Cell Biol 2012;138:699-707.
66. Malatesta M, Bertoni-Freddari C, Fattoretti P, Caporaloni C, Fakan S, Gazzanelli G. Altered RNA structural constituents in aging and vitamin E deficiency. Mech Ageing Dev 2003;124:175-181.
67. Malatesta M, Bertoni-Freddari C, Fattoretti P, Baldelli B, Fakan S, Gazzanelli G. Aging and vitamin E deficiency are responsible for altered RNA pathways. Ann N Y Acad Sci 2004;1019:379-382.
68. Salisbury E, Schoser B, Schneider-Gold C, Wang GL, Huichalaf C, Jin B, et al. Expression of RNA CCUG repeats dysregu-lates translation and degradation of proteins in myotonic dystrophy 2 patients. Am J Pathol 2009;175:748-762.
69. Huichalaf C, Sakai K, Jin B, Jones K, Wang GL, Schoser B, et al. Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells. FASEB J 2010;24:3706-3719.
70. Koopman R, van Loon LJC. Aging, exercise and muscle protein metabolism. J Appl Physiol 2009;106:2040-2048.
71. Malatesta M, Giagnacovo M, Renna LV, Cardani R, Meola G, Pellicciari C. Cultured myoblasts from patients affected by myotonic dystrophy type 2 exhibit senescence-related features: ultrastructural evidence. Eur J Histochem 2011;55:e26.
72. Ranum L P, Day JW. Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet 2004;74:793-804.